title: [Meta-iodobenzylguanidine scintigraphy of the heart].
abstract: Iodine-123 labeled metaiodobenzylguanidine (MIBG) is a noradrenaline analogue. The tracer is thought to follow the same mechanisms of uptake into cardiac sympathetic nerve endings as noradrenaline. MIBG-scintigraphy can thus be used to noninvasively image the cardiac sympathetic nervous innervation. The uptake and distribution of MIBG in the heart are changed in various cardiac diseases, and MIBG-scintigraphy has become a new research tool especially for the evaluation of patients with myocardial infarction and ischaemia, congestive heart failure and ventricular arrhythmias. This review article focuses on the cardiac diseases where MIBG-scintigraphy has contributed to a better understanding of the pathophysiology and improved clinical evaluation of the patients.
authors.forename: H D
authors.initials: HD
authors.lastname: Villadsen
authors.forename: J
authors.initials: J
authors.lastname: Abrahamsen
mesh_terms: D019797:3-Iodobenzylguanidine / Q000378:metabolism; D003327:Coronary Disease / Q000000981:diagnostic imaging*; D006321:Heart / Q000000981:diagnostic imaging*; D006331:Heart Diseases / Q000000981:diagnostic imaging*; D006801:Humans; D007457:Iodine Radioisotopes; D011877:Radionuclide Imaging
chemical_list: D007457:Iodine Radioisotopes; D019797:3-Iodobenzylguanidine